# Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

> **NCT04438837** · NA · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 582 (estimated)

## Conditions studied

- Coronavirus Disease 2019 (COVID-19)
- Post-Exposure Prophylaxis

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04438837
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 582 (ESTIMATED)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438837, "Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04438837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*